Summary:
In this podcast, you will hear a keynote presentation from Dr Rachel Haurwitz, Caribou Biosciences, from the 2022 Immuno-Oncology 360° Conference addressing the big picture view of where the cell therapy field is going and how innovative CRISPR-based editing will help with the treatment of hematologic and solid tumors.
To learn more about the Immuno-Oncology 360° Conference, please visit IO360summit.com
